Immunotherapy in Lung Cancer: Treatment After IO Cessation.
- Conditions
- Carcinoma, Non-Small-Cell LungImmunotherapy
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 300
- Registration Number
- NCT04465942
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Department of Pneumology CHU Charleroi, Charleroi, Belgium
🇧🇪Hôpital Mont-Godinne, Yvoir, Belgium
Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry
- Conditions
- Lung Neoplasm
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 200
- Registration Number
- NCT03368820
- Locations
- 🇧🇪
Hôpital Saint-Joseph, Charleroi, Belgium
🇧🇪CHU Tivoli, La Louvière, Belgium
🇧🇪CH Peltzer-La Tourelle, Verviers, Belgium
Has Inflammation a Significant Implication in Lung Cancer Evolution?
- Conditions
- Lung Neoplasms
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 400
- Registration Number
- NCT02484872
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules
- Conditions
- Pulmonary Nodule Cm
- Interventions
- Procedure: Bronchoscopy
- First Posted Date
- 2013-01-30
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 120
- Registration Number
- NCT01779388
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Carcinoma
- Interventions
- Drug: Chemotherapy
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 70
- Registration Number
- NCT00864266
- Locations
- 🇧🇪
Hôpital Ambroise Paré, Mons, Belgium
🇧🇪Department of Pneumology Clinique Saint-Luc, Bouge, Belgium
🇧🇪Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide
- Conditions
- Small Cell Lung Carcinoma
- Interventions
- Drug: Adriamycin, cyclophosphamide, vindesine, valproic acid
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 64
- Registration Number
- NCT00759824
- Locations
- 🇧🇪
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Department of Pneumology CHU Charleroi, Charleroi, Belgium
🇧🇪Department of Pneumology Hôpital Saint-Joseph, Gilly, Belgium
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
- Conditions
- Non Small Cell Lung Carcinoma
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 340
- Registration Number
- NCT00759382
- Locations
- 🇧🇪
Department of Pneumology RHMS Hôpital de la Madeleine, Ath, Belgium
🇧🇪Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
🇧🇪Department of Pneumology Hôpital Saint-Joseph, Gilly, Belgium
Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy
- Conditions
- Non Small Cell Lung Carcinoma
- Interventions
- Procedure: Lobectomy followed by concomitant mediastinal chemoradiotherapy
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 75
- Registration Number
- NCT00661011
- Locations
- 🇧🇪
Department of Pneumology Hospital Ixelles-Molière, Brussels, Belgium
🇧🇪Department of Pneumology Centre Hospitalier de Mouscron, Mouscron, Belgium
🇧🇪CH Peltzer-La Tourelle, Verviers, Belgium
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
- Conditions
- Small Cell Lung Carcinoma, Extensive Disease
- Interventions
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 361
- Registration Number
- NCT00658580
- Locations
- 🇪🇸
Medical Oncology Hospital de Sagunto, Valencia, Spain
🇬🇷Hellenic Cancer Institute - St Savas Oncology Hospital, Athens, Greece
🇧🇪Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer
- Conditions
- Non-small Cell Lung Carcinoma
- Interventions
- Drug: Concomitant Radiochemotherapy - Radiotherapy 66 Gy, Cisplatin, and DocetaxelDrug: Concomitant Chemoradiotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- European Lung Cancer Working Party
- Target Recruit Count
- 125
- Registration Number
- NCT00633568
- Locations
- 🇫🇷
Service de Pneumologie Centre Hospitalier de Douai, Douai, France
🇫🇷Service de Pneumologie Hôpital de Hayange, Hayange, France
🇫🇷Pneumology department of CHU Lille, Lille, France